MYC and neoplasm: In endometrial cancer, SPOP mutations alter estrogen receptor-α stability and enhance BET protein degradation, SPOP also regulates multiple substrates, including SRC-3, progesterone receptor, and c-Myc, to exert tumor-suppressive effects 12, 38-40.